市場調查報告書
商品編碼
1561578
2024-2032 年按類型、針長度、治療方法、購買方式、最終用戶和地區分類的筆針市場報告Pen Needles Market Report by Type, Needle Length, Therapy, Mode of Purchase, End User, and Region 2024-2032 |
2023年,全球筆用針頭IMARC Group規模達到37億美元。市場的推動因素包括糖尿病和慢性病盛行率的上升、老年人口的增加、醫療保健領域投資的增加、技術的快速進步、胰島素自我管理的不斷發展以及優惠報銷政策的實施。
糖尿病和其他慢性病的盛行率不斷增加
全球糖尿病和其他慢性疾病盛行率的上升是推動筆用針頭市場成長的主要因素。根據國際糖尿病聯盟 (IDF) 的糖尿病圖譜,到 2021 年,20 至 79 歲的成年人口中有 10.5% 患有糖尿病,其中一半以上不知道自己的診斷結果。該預測預計,到 2045 年,每 8 名成年人中就有 1 人(即近 7.83 億人)患有糖尿病,增幅約為 46%。據此,糖尿病管理需要頻繁監測和胰島素注射,這是透過配備筆針的胰島素筆來完成的。筆式針頭因其簡單易用而成為需要頻繁注射胰島素的糖尿病患者不可或缺的工具。
不斷擴大的老年人口
筆用針頭市場預測強調,老年人口的擴大是導致該市場成長的重要因素。由於與年齡相關的生理變化和較高的合併症盛行率,老年人更容易患慢性疾病,包括糖尿病。據世界衛生組織(WHO) 稱,到2050 年,全球60 歲以上人口比例預計將增加近一倍,從2015 年的12% 增至22%。產生深遠影響。此外,具有易於操作、最小疼痛和安全機制等特點的筆針對於這個年齡層的人是有益的。隨著老年人口的持續成長,針對其特定需求的產品需求預計將會增加,從而推動市場的擴張。
醫療保健領域的投資不斷成長
多個國家對醫療保健行業的資金投入不斷增加,正在加強筆針的市場佔有率。例如,2022年,歐洲政府在衛生方面的整體支出總計1,2,210億歐元,佔GDP的7.7%。同樣,印度的公共醫療保健支出在 2023 會計年度佔 GDP 的 2.1%,在 2022 會計年度佔 GDP 的 2.2%。這種擴張改善了糖尿病等疾病的診斷、監測和管理,從而增加了對筆用針頭的需求。此外,具有成本效益的保險範圍和報銷計劃的可用性一直鼓勵患者探索使用胰島素筆和筆針作為治療選擇。例如,2022 年某個時候,美國 92.1% 的人(即 3.040 億人)擁有健康保險,這也增加了筆用針頭的需求。
IMARC Group提供了每個細分市場的主要趨勢的分析,以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據類型、針頭長度、治療方法、購買方式和最終用戶對市場進行了分類。
標準筆針佔據大部分市場佔有率
該報告根據類型提供了詳細的市場細分和分析。這包括標準筆針和安全筆針。根據該報告,標準筆針代表了最大的部分。
根據筆用針頭市場前景和分析,由於患者和醫療保健提供者的廣泛使用和接受,標準筆用針頭細分市場佔據了最大佔有率。這些針頭設計適合大多數胰島素筆,並以其多功能性、易用性以及各種長度和規格的可用性而聞名。此外,標準筆針頭因其成本效益和確保與各種胰島素輸送系統相容的廣泛選擇而成為首選。除此之外,設計和技術的不斷改進提高了注射時的舒適度並減少了疼痛,對筆針的市場價值產生了積極影響。
8mm行業佔有率第一
報告中還提供了基於針長度的詳細市場細分和分析。這包括 4 毫米、5 毫米、6 毫米、8 毫米、10 毫米和 12 毫米。報告顯示,8mm佔據了最大的市場佔有率。
根據筆用針頭市場報告和趨勢,8mm 針頭長度部分在市場上佔據最大佔有率,這歸因於其平衡的功效和對廣大患者的舒適度。此長度被認為是皮下胰島素輸送的最佳長度,確保充分滲透到皮下組織,同時最大限度地降低肌肉注射的風險。此外,8毫米針頭因其多功能性而受到醫療保健提供者的廣泛推薦,適合成人和兒童。同時,8毫米針頭在臨床實踐中的廣泛使用,加上患者的熟悉和接受,正在擴大筆用針頭的市場規模。
胰島素代表領先的市場
該報告根據該療法提供了詳細的市場區隔和分析。這包括胰島素、GLP-1 和生長激素。根據該報告,胰島素佔了最大的佔有率。
根據筆用針頭市場概況和細分,由於糖尿病盛行率不斷上升以及注射胰島素以進行有效疾病管理的必要性,胰島素治療佔據了最大佔有率。與此一致的是,胰島素治療需要頻繁且精確的注射,因此筆針成為糖尿病患者的必備工具。此外,筆針的便利性、準確性和疼痛的減少提高了患者的依從性和生活品質,這也促進了市場的成長。此外,先進胰島素筆的開發和產品技術的不斷創新正在支撐筆針市場價格趨勢。
零售業在市場上表現出明顯的主導地位
報告還根據購買方式對市場進行了詳細的細分和分析。這包括零售和非零售。報告稱,零售業佔據最大的市場佔有率。
根據筆針市場研究報告,零售領域佔據了最大的佔有率,這得益於它為消費者提供的便利性和可及性。零售藥局和網路商店為患者提供了一個簡單、即時的存取點,因為它們可以提供快速的用品,而無需前往醫療機構。除此之外,廣泛的零售通路分銷網路確保了產品的廣泛供應,滿足城鄉人口的需求。此外,零售店還提供各種品牌和產品,使患者可以選擇最適合其需求和偏好的筆用針頭。
醫院和診所主導市場
該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所、家庭醫療保健等。報告稱,醫院和診所是最大的部分。
醫院和診所構成了最大的部分,這是由於在這些環境中進行的大量醫療程序和慢性病管理所推動的。他們是初級醫療保健提供者,大量糖尿病患者接受診斷、治療計劃和持續管理,因此需要穩定供應用於胰島素注射和其他注射療法的筆針。此外,這些醫療機構優先考慮患者的安全和療效,選擇高品質的針頭以確保精確、舒適的藥物輸送。此外,醫院和診所是對患者進行正確使用這些針頭教育的第一站,從而促進了市場成長。
歐洲引領市場,佔據最大的筆用針頭市場佔有率
該報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,歐洲是筆用針最大的區域市場。
在糖尿病高盛行率、先進的醫療基礎設施和政府支持政策的共同推動下,歐洲在筆用針頭行業佔據了最大的佔有率。與此一致的是,強大的醫療保健系統提供了廣泛的糖尿病管理工具,再加上強力的報銷框架的增加支持,減輕了患者的經濟負擔,正在推動市場成長。除此之外,人們對糖尿病照護的高度認知,以及積極的公共衛生運動和促進使用這些筆的教育計劃,有利於市場的成長。此外,幾家領先的醫療設備製造商的存在促進了創新並提高了先進針頭技術的可用性,這刺激了筆針頭市場的收入。
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
The global pen needles market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.3 Billion by 2032, exhibiting a growth rate (CAGR) of 12.7% during 2024-2032. The market is driven by the rising prevalence of diabetes and chronic diseases, expanding geriatric population, increasing investment in the healthcare sector, rapid technological advancements, growing self-administration of insulin, and the imposition of favorable reimbursement policies.
Increasing Prevalence of Diabetes and Other Chronic Diseases
The rising prevalence of diabetes and other chronic diseases across the globe is a major factor driving the pen needles market growth. According to the International Diabetes Federation's (IDF) Diabetes Atlas, 10.5% of the adult population aged 20 to 79 had diabetes in 2021, with over half unaware of the diagnosis. By 2045, this forecast predicts that one in every eight adults, or nearly 783 million, will have diabetes, which is an approximately 46% rise. In line with this, diabetes management necessitates frequent monitoring and insulin administration, which is accomplished with insulin pens equipped with pen needles. Pen needles are an indispensable tool for diabetes patients who require frequent insulin injections due to their ease and user-friendliness.
Expanding Geriatric Population
The pen needles market forecast highlights that the expanding geriatric population is a significant factor that is resulting in the growth of this market. Geriatric adults are more susceptible to chronic diseases, including diabetes, due to age-related physiological changes and a higher prevalence of comorbidities. According to the World Health Organization (WHO), the proportion of the world's population over 60 years is projected to nearly double from 12% in 2015 to 22% by 2050. This demographic shift has profound implications for healthcare systems and the demand for medical devices. Additionally, pen needles that are designed with features like easy handling, minimal pain, and safety mechanisms are beneficial for this age group. As the geriatric population continues to grow, the demand for products that are tailored to their specific needs is expected to increase, driving the expansion of the market.
Growing Investment in the Healthcare Sector
The increasing funding in the healthcare industry by several countries is strengthening the pen needle market share. For example, in 2022, Europe's overall government spending on health totaled €1221 billion, or 7.7% of GDP. Similarly, India's public healthcare spending accounted for 2.1% of GDP in FY23 and 2.2% in FY22. This expansion has been allowing for improved diagnosis, monitoring, and management of illnesses such as diabetes, which drives up the demand for pen needles. Furthermore, the availability of cost-effective insurance coverage and reimbursement schemes have been encouraging patients to explore the use of insulin pens and pen needles as a treatment option. For instance, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during 2022, which also increased the pen needles demand.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, needle length, therapy, mode of purchase, and end user.
Standard pen needles accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes standard pen needles and safety pen needles. According to the report, standard pen needles represented the largest segment.
As per the pen needles market outlook and analysis, the standard pen needles segment represented the largest share, driven by their widespread usage and acceptance among patients and healthcare providers. These needles are designed to fit most insulin pens and are known for their versatility, ease of use, and availability in various lengths and gauges. Moreover, standard pen needles are preferred due to their cost-effectiveness and the broad range of options that ensure compatibility with various insulin delivery systems. Besides this, the continuous improvements in design and technology, which enhance comfort and reduce pain during injections, are positively impacting the pen needle market value.
8mm holds the largest share of the industry
A detailed breakup and analysis of the market based on the needle length have also been provided in the report. This includes 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. According to the report, 8mm accounted for the largest market share.
Based on the pen needles market report and trends, the 8mm needle length segment holds the largest share in the market, attributed to its balanced efficacy and comfort for a wide range of patients. This length is considered optimal for subcutaneous insulin delivery, ensuring adequate penetration to the subcutaneous tissue while minimizing the risk of intramuscular injection. Moreover, the 8mm needles are widely recommended by healthcare providers due to their versatility, making them suitable for adults and children. Along with this, the extensive use of 8mm needles in clinical practice, coupled with patient familiarity and acceptance, is enhancing the pen needles market size.
Insulin represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the therapy. This includes insulin, GLP-1, and growth hormones. According to the report, insulin represented the largest segment.
According to the pen needles market overview and segmentation, insulin therapy constituted the largest share, driven by the growing prevalence of diabetes and the necessity of insulin administration for effective disease management. In line with this, insulin therapy requires frequent and precise injections, making pen needles an essential tool for diabetic patients. Moreover, the rising convenience, accuracy, and reduced pain associated with pen needles that enhance patient compliance and quality of life are contributing to the market growth. Additionally, the development of advanced insulin pens and continuous innovations in product technology are supporting the pen needle market price trends.
Retail exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on the mode of purchase have also been provided in the report. This includes retail and non-retail. According to the report, retail accounted for the largest market share.
As per the pen needles market research report, the retail segment represented the largest share, driven by the convenience and accessibility it offers to consumers. Retail pharmacies and online stores provide an easy and immediate access point for patients as they offer quick supplies without the need for a medical facility visit. Besides this, the broad distribution networks of retail channels ensure widespread availability, catering to urban and rural populations. Additionally, retail outlets offer a variety of brands and products, allowing patients to choose pen needles that best meet their needs and preferences.
Hospitals and clinics dominate the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, home healthcare, and others. According to the report, hospitals and clinics represented the largest segment.
Hospitals and clinics constituted the largest segment, driven by the high volume of medical procedures and chronic disease management performed in these settings. They are primary healthcare providers where a significant number of diabetes patients receive their diagnosis, treatment plans, and ongoing management, necessitating a steady supply of pen needles for insulin administration and other injectable therapies. Moreover, these healthcare facilities prioritize patient safety and efficacy, opting for high-quality needles to ensure precise and comfortable medication delivery. Additionally, hospitals and clinics serve as the first point of education for patients on the correct use of these needles, boosting the market growth.
Europe leads the market, accounting for the largest pen needles market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe represents the largest regional market for pen needles.
Europe holds the largest segment in the pen needles industry, driven by a combination of high diabetes prevalence, advanced healthcare infrastructure, and supportive government policies. In line with this, the robust healthcare systems that provide extensive access to diabetes management tools, coupled with increased support from strong reimbursement frameworks that reduce the financial burden on patients, are boosting the market growth. Along with this, the high awareness of diabetes care, with proactive public health campaigns and educational programs that promote the use of these pens, is favoring the market growth. Additionally, the presence of several leading medical device manufacturers that foster innovation and boost the availability of advanced needle technologies is stimulating the pen needle market revenue.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)